JavaScript is disabled. Please enable to continue!
Mobile search icon
Eurofins >> BioPharma Services >> Genomic Services

Pharma and Translational Medicine Matching Genomic Solutions

Sidebar Image

Total genomic solutions offered by Eurofins Genomics

Many years of experience in the field of genetic analysis, crucial for the entire drug development and production process, make Eurofins Genomics a leading provider of total genomic solutions.

Benefit from a broad spectrum of services in the areas of analysis, research and development. Primary activities of Eurofins Genomics include services within molecular analyses of RNA and DNA from a wide range of species and specimens – always with a consultative approach.

Custom services and highly flexible laboratories dedicated to quality performance

Eurofins Genomics company is offering services specially tailored for the Pharmaceutical field, Companion Diagnostics and Translational Medicine. Pharmaceutical customers from 27 different countries across Europe, US and Asia confirm this.

With multiple specialized technological platforms Eurofins Genomics covers the entire value chain:

  • Target identification
  • Target validation
  • Biomarker discovery and validation
  • Preclinical development
  • Clinical development: phases I, II and III
  • Post approval
  • Manufacturing

Applications – Optimised for pharmaceutical, biotech and translational medicine needs

DNA, RNA and miRNA extraction

  • Various stabilisation and preparation methods like EDTA, PAXgene tubes, FF, FFPE
  • High throughput nucleic extraction and aliquotation pipeline for biobanking purposes

Sanger sequencing

  • Sanger based genotyping
  • Genetic stability testing (GLP sequencing)
  • Resequencing

Next generation sequencing

  • RNA sequencing
  • Exome sequencing
  • Whole genome sequencing
  • Metagenomics
  • Adventitious virus testing via MPS
  • Genetic stability testing under GLP

qPCR expression and genotyping

  • Ready to use pharmacogenetics assays
  • Assay development and execution
  • High-throughput and flexibility

Microarrays for gene expression and genotyping

  • New generation expression array
  • Epigenetics: Methylation and miRNA
  • Pharmacogenomics: DMET
  • Oncology
  • Cytogenetics
  • GWAS and targeted arrays like the HLA Biobank array